Twist Bioscience Corp (TWST) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 1080 transactions totaling $142.0M, demonstrating a bearish sentiment with -$141.2M in net insider flow. The most recent transaction on Jan 23, 2026 involved a sale of 2,390 shares valued at $107.3K.
No significant insider buying has been recorded for TWST in the recent period.
No significant insider selling has been recorded for TWST in the recent period.
Based on recent SEC filings, insider sentiment for TWST is bearish with an Insider Alignment Score of 0/100 and a net flow of -$141.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Twist Bioscience Corp (TWST) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading TWST stock, having executed 1080 transactions in the past 90 days. The most active insider is Emily M. Leproust (Executive), who has made 243 transactions totaling $78.7M.
Get notified when executives and directors at TWST file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | John Finn Patrick | President and COO | Sale | 2,390 | $44.91 | $107.3K | C-Suite |
| Jan 9, 2026 | Laponis Adam | Chief Financial Officer | Sale | 2,738 | $35.26 | $96.5K | C-Suite |
| Dec 22, 2025 | M. Leproust Emily | Executive | Sale | 1,605 | $34.56 | $55.5K | |
| Dec 22, 2025 | Cho Dennis | Executive | Sale | 324 | $34.56 | $11.2K | |
| Dec 22, 2025 | Green Paula | Executive | Sale | 273 | $34.56 | $9.4K | |
| Dec 8, 2025 | F. Werner Robert | Executive | Sale | 230 | $32.88 | $7.6K | |
| Dec 8, 2025 | Green Paula | Executive | Sale | 877 | $32.88 | $28.8K | |
| Dec 8, 2025 | M. Leproust Emily | Executive | Sale | 2,255 | $32.88 | $74.1K | |
| Dec 8, 2025 | Cho Dennis | Executive | Sale | 398 | $32.88 | $13.1K | |
| Nov 24, 2025 | F. Werner Robert | Executive | Sale | 822 | $28.71 | $23.6K | |
| Nov 21, 2025 | F. Werner Robert | Executive | Sale | 229 | $26.50 | $6.1K | |
| Nov 21, 2025 | M. Leproust Emily | Executive | Sale | 2,663 | $26.50 | $70.6K | |
| Nov 21, 2025 | Laponis Adam | Executive | Sale | 887 | $26.50 | $23.5K | |
| Nov 21, 2025 | Green Paula | Executive | Sale | 598 | $26.50 | $15.8K | |
| Nov 21, 2025 | John Finn Patrick | Executive | Sale | 1,776 | $26.50 | $47.1K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 522 | $141.6M | 80.2% |
Gift(G) | 13 | $15.6M | 8.8% |
Payment(F) | 301 | $10.3M | 5.8% |
Exercise(M) | 146 | $8.3M | 4.7% |
Purchase(P) | 2 | $382.1K | 0.2% |
Award(A) | 84 | $280.8K | 0.2% |
Other(J) | 12 | $0 | 0.0% |
Insider selling pressure at Twist Bioscience Corp has increased, with 20 insiders executing 1080 transactions across all time. Total sales of $141.6M significantly outpace purchases of $382.1K, resulting in a net outflow of $141.2M. This selling activity appears largely discretionary, which may warrant closer attention from investors.